SECOND REGULAR SESSION
SENATE BILL NO. 1429
102ND GENERA L ASSEMBLY
INTRODUCED BY SENATOR CARTER.
5804S.01I KRISTINA MARTIN, Secretary
AN ACT
To amend chapter 191, RSMo, by adding thereto one new section relating to blood donations.
Be it enacted by the General Assembly of the State of Missouri, as follows:
1 Section A. Chapter 191, RSMo, is amended by adding thereto
2 one new section, to be known as section 191.763, to read as
3 follows:
1 191.763. 1. As used in this section, the following
2 terms mean:
3 (1) "Blood bank", any institution, building, or place
4 that provides, through its ownership or operation, a system
5 for the collection, processing, storage, distribution, or
6 administration of whole human blood or its component parts;
7 (2) "Person", any individual; firm; partnership;
8 association; corporation, whether organized for profit or
9 otherwise; or other form of business enterprise.
10 2. A blood bank shall test or have tested donated
11 blood for evidence of any COVID-19 vaccine or any other
12 messenger ribonucleic acid (mRNA) vaccine components,
13 including evidence of lipid nanoparticles and spike protein
14 from a vaccine.
15 3. If blood tests positive for evidence of a COVID-19
16 vaccine or any other mRNA vaccine components, the following
17 procedures shall be required for such blood:
18 (1) The person who withdrew the blood or separated the
19 blood into components by physical processes shall affix to
SB 1429 2
20 each container of such blood or blood components a label
21 that includes a designation of such positive status; and
22 (2) No person shall administer such blood by
23 transfusion in this state or transfer or offer to transfer
24 such blood for transfusion purposes by any type of
25 transaction unless the following requirements have been
26 satisfied:
27 (a) The container of the blood is affixed with the
28 label required under subdivision (1) of this subsection; and
29 (b) The person receiving the transfusion, or the
30 authorized representative of the person, has acknowledged
31 that the person or representative was given the opportunity
32 to refuse blood labeled with the designation described in
33 subdivision (1) of this subsection.
ïƒ¼